Not yet recruiting
Hepatocellular carcinoma
Not yet recruitingAdvanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
Registered drugNo placebo
Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
Registered drugNo placebo
- Disease:Hepatocellular carcinoma
- Substances:AtezolizumabBevacizumab+6
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:Azienda Sanitaria Locale Napoli 1 Centro
